Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (unaudited)

v3.21.2
Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 305,556 $ 204,727 $ 822,400 $ 728,205
Cost of goods sold 308,955 183,797 796,729 688,983
Gross profit (loss) (3,399) 20,930 25,671 39,222
Selling, general and administrative expenses (5,533) (6,404) (19,777) (25,245)
Asset impairments (3,100)
Gain on litigation settlement 11,750 11,750
Income (loss) from operations (8,932) 26,276 2,794 25,727
Interest expense, net (429) (4,199) (3,359) (14,153)
Income from loan forgiveness 5,973 9,860
Fair value adjustments (6,856) (7,497)
Other income (expense), net 256 (6) 641 (1,164)
Income (loss) before benefit for income taxes (3,132) 15,215 9,936 2,913
Benefit for income taxes
Consolidated net income (loss) (3,132) 15,215 9,936 2,913
Net loss attributed to noncontrolling interests 2,166
Net income (loss) attributed to Alto Ingredients, Inc. (3,132) 15,215 9,936 5,079
Preferred stock dividends (319) (319) (946) (949)
Net income (loss) available to common stockholders $ (3,451) $ 14,896 $ 8,990 $ 4,130
Net income (loss) per share, basic (in Dollars per share) $ (0.05) $ 0.25 $ 0.13 $ 0.07
Net income (loss) per share, diluted (in Dollars per share) $ (0.05) $ 0.24 $ 0.12 $ 0.07
Weighted-average shares outstanding, basic (in Shares) 71,383,000 58,503,000 71,002,000 55,620,000
Weighted-average shares outstanding, diluted (in Shares) 71,383,000 61,699,000 72,260,000 57,958,000